These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32407795)

  • 1. Short-Course External Beam Radiotherapy Versus Brachytherapy for Palliation of Dysphagia in Esophageal Cancer: A Matched Comparison of Two Prospective Trials.
    Jeene PM; Vermeulen BD; Rozema T; Braam PM; Lips I; Muller K; van Kampen D; Homs MYV; Oppedijk V; Berbée M; van Rossum PSN; El Sharouni S; Siersema PD; Hulshof MCCM;
    J Thorac Oncol; 2020 Aug; 15(8):1361-1368. PubMed ID: 32407795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported outcomes after external beam radiotherapy versus brachytherapy for palliation of dysphagia in esophageal cancer: A matched comparison of two prospective trials.
    van Rossum PSN; Jeene PM; Rozema T; Braam PM; Lips IM; Muller K; van Kampen D; Vermeulen BD; Homs MYV; Oppedijk V; Berbée M; Hulshof MCCM; Siersema PD; El Sharouni SY
    Radiother Oncol; 2021 Feb; 155():73-79. PubMed ID: 33065190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dose Versus High-Dose Radiation Therapy for the Palliation of Dysphagia From Esophageal Cancer: A Multicenter Retrospective Cohort Study.
    Vermeulen BD; Jeene PM; Sijben J; Krol R; Rütten H; Bogers JA; Braam PM; Siersema PD
    Pract Radiat Oncol; 2020; 10(4):e255-e263. PubMed ID: 31669401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External beam radiotherapy versus brachytherapy in the management of malignant oesophageal dysphagia: a retrospective study.
    Eldeeb H; Reza S; Shmueli U; Logsdail G; Hinks P; Mukherjee S
    J BUON; 2012; 17(3):508-11. PubMed ID: 23033290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer.
    Sur R; Donde B; Falkson C; Ahmed SN; Levin V; Nag S; Wong R; Jones G
    Brachytherapy; 2004; 3(4):191-5. PubMed ID: 15607150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of radical external beam radiotherapy versus external beam radiotherapy combined with intraluminal brachytherapy for primary esophageal cancer.
    Ye M; Han D; Mao Z; Cheng G
    Brachytherapy; 2022; 21(5):703-711. PubMed ID: 35787969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center.
    Bhatt L; Tirmazy S; Sothi S
    Dis Esophagus; 2013 Jan; 26(1):57-60. PubMed ID: 22404484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer.
    Homs MY; Steyerberg EW; Eijkenboom WM; Siersema PD;
    Brachytherapy; 2006; 5(1):41-8. PubMed ID: 16563996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.
    Sur RK; Donde B; Levin VC; Mannell A
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):447-53. PubMed ID: 9457834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined brachytherapy and external beam radiation: an effective approach for palliation in esophageal cancer.
    Laskar SG; Lewis S; Agarwal JP; Mishra S; Mehta S; Patil P
    J Contemp Brachytherapy; 2015 Dec; 7(6):453-61. PubMed ID: 26816502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative stenting with or without radiotherapy for inoperable esophageal carcinoma: a randomized trial.
    Javed A; Pal S; Dash NR; Ahuja V; Mohanti BK; Vishnubhatla S; Sahni P; Chattopadhyay TK
    J Gastrointest Cancer; 2012 Mar; 43(1):63-9. PubMed ID: 20835926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brachytherapy in the Palliation of Oesophageal Cancer: Effective but Impractical?
    Sinha S; Varagunam M; Park MH; Maynard ND; Trudgill N; Crosby T; Cromwell DA
    Clin Oncol (R Coll Radiol); 2019 Jul; 31(7):e87-e93. PubMed ID: 30982667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study.
    Spencer GM; Thorpe SM; Blackman GM; Solano J; Tobias JS; Lovat LB; Bown SG
    Gut; 2002 Feb; 50(2):224-7. PubMed ID: 11788564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases.
    Ghosh S; Sau S; Mitra S; Manna A; Ghosh K
    J Indian Med Assoc; 2012 Jul; 110(7):449-52. PubMed ID: 23520668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial.
    Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD
    Lancet; 2004 Oct 23-29; 364(9444):1497-504. PubMed ID: 15500894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of radical dose escalation by endoluminal brachytherapy and induction chemotherapy in the definitive treatment of locally advanced esophageal cancer - A retrospective study.
    Raghunath S; Tiwari R; Rashmi S; Geetha SN; Sulthana R; Madabhavi I
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S280-S284. PubMed ID: 36510977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative brachytherapy and external beam radiotherapy for dysphagia from esophageal cancer: a nationwide survey in Japan.
    Kawamoto T; Nakamura N; Saito T; Tonari A; Wada H; Harada H; Kubota H; Nagakura H; Heianna J; Miyazawa K; Yamada K; Tago M; Fushiki M; Nozaki M; Uchida N; Araki N; Sekii S; Kosugi T; Takahashi T; Shikama N
    Jpn J Clin Oncol; 2021 May; 51(6):950-955. PubMed ID: 33624768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WITHDRAWN: Interventions for dysphagia in oesophageal cancer.
    Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
    Cochrane Database Syst Rev; 2011 Feb; (2):CD005048. PubMed ID: 21328271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for dysphagia in oesophageal cancer.
    Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD005048. PubMed ID: 19821338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brachytherapy for the palliation of dysphagia owing to esophageal cancer: A systematic review and meta-analysis of prospective studies.
    Fuccio L; Mandolesi D; Farioli A; Hassan C; Frazzoni L; Guido A; de Bortoli N; Cilla S; Pierantoni C; Violante FS; Bazzoli F; Repici A; Morganti AG
    Radiother Oncol; 2017 Mar; 122(3):332-339. PubMed ID: 28104297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.